trifluridine has been researched along with Experimental Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HEIDELBERGER, C; PARSONS, DG; REMY, DC | 1 |
BOOHAR, J; HEIDELBERGER, C; KAMPSCHROER, B | 1 |
Clive, D | 1 |
Hopper, KE; Nelson, DS; Nelson, M | 1 |
Asao, T; Emura, T; Fukushima, M; Kazuno, H; Suzuki, N; Tada, Y; Yamada, Y; Yano, S | 1 |
Boothman, DA; Greer, SB; Mekras, JA | 1 |
6 other study(ies) available for trifluridine and Experimental Neoplasms
Article | Year |
---|---|
SYNTHESES OF 5-TRIFLUOROMETHYLURACIL AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
Topics: Adenocarcinoma; Antineoplastic Agents; Chemistry, Pharmaceutical; Coliphages; DNA; DNA, Viral; Mice; Neoplasms, Experimental; Nucleosides; Pharmacology; Pyrimidines; Research; Trifluridine; Uracil | 1964 |
FLUORINATED PYRIMIDINES. XXIV. IN VIVO METABOLISM OF 5-TRIFLUOROMETHYLURACIL-2-C-14 AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE-2-C-14.
Topics: Animals; Carbon Isotopes; Deoxyuridine; DNA; Fluorine; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Nucleosides; Pyrimidines; Radiometry; Research; Trifluridine; Uracil | 1965 |
Viable chromosomal mutations affecting the TK locus in L5178Y/TK+/- mouse lymphoma cells: the other half of the assay.
Topics: Animals; Cell Line; Chromosome Aberrations; Lymphoma; Mice; Mutagenicity Tests; Mutation; Neoplasms, Experimental; Thymidine Kinase; Trifluridine | 1983 |
I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.
Topics: Animals; Blood Cell Count; Blood Sedimentation; Corticosterone; Cyclophosphamide; Female; Fibrosarcoma; Immunity, Active; In Vitro Techniques; Injections, Subcutaneous; Macrophages; Male; Methylcholanthrene; Mice; Neoplasms, Experimental; Premedication; Reserpine; Time Factors; Trifluridine | 1981 |
Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Dogs; Drug Synergism; Enzyme Inhibitors; Female; Humans; Idoxuridine; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Placenta; Pyrrolidines; Recombinant Proteins; Structure-Activity Relationship; Thymidine; Thymidine Phosphorylase; Trifluridine; Uracil | 2000 |
Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cytidine Deaminase; Deoxycytidine; DNA; Female; Floxuridine; Fluorouracil; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Nucleoside Deaminases; Tetrahydrouridine; Thymidylate Synthase; Trifluridine; Uridine | 1985 |